Stockscreener 앱 받기
0.3011
0.84%
0.0025
전일 마감가:
$0.2986
열려 있는:
$0.29
하루 거래량:
1.58M
Relative Volume:
2.74
시가총액:
$7.22M
수익:
-
순이익/손실:
$-6.07M
주가수익비율:
-0.0521
EPS:
-5.78
순현금흐름:
$-7.34M
1주 성능:
-7.38%
1개월 성능:
-15.75%
6개월 성능:
-57.70%
1년 성능:
-70.48%
1일 변동 폭
$0.283
$0.3091
1주일 범위
$0.283
$0.3298
52주 변동 폭
$0.22
$1.30
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
명칭
Adial Pharmaceuticals Inc
전화
434-422-9800
주소
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
ADIL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
0.3011 | 7.16M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-14 | 개시 | Rodman & Renshaw | Buy |
| 2018-10-30 | 개시 | Maxim Group | Buy |
| 2018-10-11 | 개시 | Dawson James | Buy |
Adial Pharmaceuticals Inc 주식(ADIL)의 최신 뉴스
Is Adial Pharmaceuticals Inc a good long term investmentMoving Average Crossovers & Learn to Pick Stocks in Under 10 Minutes - earlytimes.in
Why Adial Pharmaceuticals Inc. stock could rally in 20252025 Year in Review & Expert Verified Movement Alerts - newser.com
Will Adial Pharmaceuticals Inc. stock deliver strong dividend growthJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com
Why Adial Pharmaceuticals Inc. stock could benefit from AI revolutionProfit Target & Safe Capital Growth Plans - newser.com
What high frequency data says about Adial Pharmaceuticals Inc.Quarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
Detecting price anomalies in Adial Pharmaceuticals Inc. with AIJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Is this a good reentry point in Adial Pharmaceuticals Inc.July 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - MarketScreener
Will Adial Pharmaceuticals Inc. stock benefit from infrastructure spendingJuly 2025 Drop Watch & Verified Technical Trade Signals - newser.com
Forecasting Adial Pharmaceuticals Inc. price range with options data2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
Can Adial Pharmaceuticals Inc. stock withstand economic slowdownJuly 2025 Selloffs & Short-Term High Return Strategies - newser.com
Will Adial Pharmaceuticals Inc. stock continue upward momentumStock Surge & Reliable Price Breakout Signals - newser.com
Adial Pharmaceuticals' Loss Shrinks As Hopes For AD04 Grow - Finimize
Should I hold or sell Adial Pharmaceuticals Inc. stock in 2025Portfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Adial Pharmaceuticals (ADIL) Advances Towards FDA Approval with AD04 - GuruFocus
Adial Pharmaceuticals Q3 net loss beats expectations on lower R&D expenses - MarketScreener
Adial (NASDAQ: ADIL) outlines 2026 cash runway and FDA End of Phase 2 guidance for lead drug - Stock Titan
Full technical analysis of Adial Pharmaceuticals Inc. stockPortfolio Gains Report & Proven Capital Preservation Methods - newser.com
Real time social sentiment graph for Adial Pharmaceuticals Inc.Weekly Stock Summary & Consistent Growth Equity Picks - newser.com
Adial Pharmaceuticals (ADIL) to Release Quarterly Earnings on Wednesday - Defense World
Why analysts upgrade Adial Pharmaceuticals Inc. stockGap Up & Low Risk High Win Rate Stock Picks - newser.com
How hedge fund analytics apply to Adial Pharmaceuticals Inc. stockWeekly Risk Report & Growth-Oriented Investment Plans - newser.com
Heatmap analysis for Adial Pharmaceuticals Inc. and competitorsTrade Ideas & Verified Stock Trade Ideas - newser.com
Adial Pharmaceuticals Inc (ADIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):